Menu Search
Equities

China Resources Pharmaceutical Group Ltd

640:STU

China Resources Pharmaceutical Group Ltd

Actions
  • Price (EUR)0.635
  • Today's Change-0.005 / -0.78%
  • Shares traded0.00
  • 1 Year change+8.55%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED is a Hongkong-based investment holding company. The Company, along with its subsidiaries, is principally engaged in the research and development, manufacturing, distribution and retail of pharmaceutical and other healthcare products. The Company mainly operates through three segments. Pharmaceutical Manufacturing segment is engaged in the research and development, manufacturing and sale of pharmaceutical and other healthcare products. Pharmaceutical Distribution segment is engaged in the provision of distribution solutions to pharmaceutical manufacturers and dispensers, such as hospitals and other medical institutions, distributors and retail pharmacies. Pharmaceutical Retail segment is involved in the operation of retail pharmacies in China and Hongkong.

  • Revenue in HKD (TTM)269.14bn
  • Net income in HKD4.06bn
  • Incorporated2007
  • Employees72.76k
  • Location
    China Resources Pharmaceutical Group LtdRoom 4104-05, 41F,China Resources BuldngNo. 26, Harbour Road, Wan Chai Hong KongHKG
  • Phone+852 25938991
  • Fax+852 25938992
  • Websitehttps://www.crpharm.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.